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noxious stimuli during the perioperative period (ie, dis-
section, overdistention to secure side branch ligation,
ischemia, chemical cardioplegia, and enhanced
mechanical stress in the arterial circulation). Long-term
patency of the SV grafts has been compromised by
neointimal formation and subsequent progression of
atherosclerosis.1-3 Thus improvement of the outcome of
surgical revascularization depends on the suppression
of such undesirable vascular remodeling. However, the
exact molecular mechanism for neointimal formation in
SV grafts remains unknown.
There is a growing body of evidence that vacuolar-
type H+–adenosine triphosphatase (V-ATPase) plays a
crucial role in regulating cell growth.4-6 V-ATPases
reside on the membranes of acidic organelles such as
synaptic vesicles, chromaffin granules, platelet dense
granules, secretary granules, lysosomes, and the trans-
Golgi network and maintain an acidic environment by
N eointimal formation is known to develop in saphe-nous vein (SV) grafts after coronary artery bypass
surgery. The SV grafts are prone to have a number of
Objective: Vacuolar H+–adenosine triphosphatase plays a pivotal role in pH
regulation and molecular transport across the vacuolar membranes and is
involved in cell proliferation and transformation. In the present study, possi-
ble involvement of vacuolar H+–adenosine triphosphatase in neointimal for-
mation was investigated in an organ culture model of human saphenous vein. 
Methods and results: Cultured saphenous vein segments developed neointi-
mal formation and marked thickening of the media within 14 days.
Neointimal formation and medial thickening were completely inhibited by
10 nmol/L bafilomycin A1, a selective inhibitor of vacuolar H+-adenosine
triphosphatase, although structurally related macrolide antibiotics FK-506
and erythromycin were without an effect. The neointimal cells were positive
for α-smooth muscle actin and vimentin but negative for desmin, indicative
of myofibroblasts. The emergence of myofibroblasts was inhibited, and
endothelial cells were preserved in the saphenous vein segments treated with
bafilomycin A1. Uptake of bromodeoxyuridine, a proliferation marker, by
myofibroblasts was abrogated in the saphenous vein segments treated with
10 nmol/L bafilomycin A1. Detection of apoptotic cells by terminal
deoxynucleotidyl transferase–mediated dUTP nick end labeling concomitant
with identification of desmin-expressing smooth muscle cells demonstrated
that neointimal myofibroblasts, but not medial smooth muscle cells, that
expressed desmin underwent apoptosis by treatment with bafilomycin A1. 
Conclusions: These results suggest that vacuolar H+–adenosine triphos-
phatase may be involved in myofibroblast growth that contributes to neoin-
timal formation and medial thickening in cultured human saphenous vein.
Increased sensitivity of myofibroblasts, but not endothelial cells, and differ-
entiated smooth muscle cells to bafilomycin A1 may have potential thera-
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pumping protons with the energy of adenosine triphos-
phate (ATP) hydrolysis.7-9 The acidic pH within such
organelles is proposed to be necessary for cell growth
and differentiation.10-12
V-ATPases are highly sensitive to bafilomycin A1
(BA1), a macrolide antibiotic with a 16-membered lac-
tone ring isolated from Streptomyces griseus.14 In vitro
sensitivity assay of different ATPases to BA1 revealed
that V-ATPases were inhibited by nanomolar concen-
trations of BA1, whereas mitochondrial H+- ATPase and
gastric H+-ATPase activities were not affected by BA1
at concentrations up to 1 mmol/L.14 This highly selec-
tive nature of BA1 to inhibit V-ATPases has been taken
advantage of as a probe in clarifying the role of V-
ATPases in various experimental models. Ohta and col-
leagues15 have demonstrated that BA1 inhibits the
growth of the human cancer cell line Capan-1 in vivo in
the rat. Our recent study has proved that BA1 is capable
of inhibiting neointimal hyperplasia in the cryopre-
served rat aortic allograft.16 The potential role of V-
ATPase in tumorigenesis prompted us to investigate the
inhibitory effect of BA1 on neointimal formation in cul-
tured human SV. The results of the present study sug-
gest that neointimal myofibroblasts, but not endothelial
cells, and differentiated smooth muscle cells are sus-
ceptible to inhibition of V-ATPase.
Methods
Preparation of SV segments. Segments of freshly pre-
pared SV were obtained from 40 patients (37 male patients;
age, 64.2 ± 7.4 years [range, 51-80 years]) who underwent
coronary artery bypass operations. Informed consent was
obtained from those patients according to the ethical permis-
sion issued by the Ethical Committee of Kansai Medical
University. A segment (approximately 2 cm) of SV was
obtained immediately after dissection and collected in tissue
culture medium (RPMI 1640 [Roswell Park Memorial
Institute, Buffalo, NY] with HEPES buffer, 20 mmol/L, pH
7.4) containing sodium heparin, 4 IU/mL.
Tissue culture procedures. The SV segment was freed of
excess fat and connective tissue under sterile conditions,
opened with the luminal surface uppermost, and cut approxi-
mately into 1-cm segments. The SV segments were then incu-
bated in RPMI 1640 medium containing sodium bicarbonate
supplemented with glutamate (2 mmol/L), 30% fetal bovine
serum and penicillin: streptomycin, 100 µg/mL.
Medium pH was adjusted to 7.35 to 7.45 by adding sodi-
um hydroxide, if necessary, during incubation in a 5% car-
bon dioxide–air incubator at 37°C. The tissue culture medi-
um was changed every 48 to 72 hours. BA1, concanamycin
A, erythromycin (obtained from Sigma Chemical Co, St
Louis, Mo), and FK-506 (generous gift from Fujisawa
Pharmaceutical Co, Tokyo, Japan) were dissolved in
dimethylsulfoxide and diluted with tissue culture medium to
yield desired concentrations (5 nmol/L–1 µmol/L) and 0.1%
dimethylsulfoxide. Control cultures were performed with
medium containing 0.1% dimethylsulfoxide. The effect of
BA1 on cell proliferation was examined in cultured SV seg-
ments, which were supplemented with 50 µmol/L of 5-
bromo-2´-deoxyuridine (BrdU) in the presence or absence
of BA1 between days 11 and 12 in culture. At the end of the
cultivation, the SV segments were fixed with 10%
formaldehyde in 0.1 mol/L phosphate buffer, pH 7.2, for
light microscopy, or with 2.5% glutaraldehyde in 0.1 mol/L
sucrose/sodium cacodylate HCl buffer, pH 7.2, for electron
microscopy. The glutaraldehyde-fixed SV segments were
postfixed in 1% osmium tetroxide, dehydrated, critical point
dried in liquid carbon dioxide, and viewed with a scanning
electron microscope (Hitachi S-700; Hitachi, Tokyo, Japan).
The dehydrated sections were embedded also in Epon 812
fixative, cut with a diamond knife, double stained with
uranyl acetate and lead citrate, and examined on a transmis-
sion electron microscope (Hitachi H-7000; Hitachi).
Immunohistochemistry. The formaldehyde-fixed and
paraffin-embedded segments were cut into 4 µm-thick sec-
tions and deparaffinized. The sections were incubated with
proteinase K (Roche Molecular Biochemicals [formerly
Boehringer-Mannheim Biochemica, Mannheim, Germany])
at a concentration of 40 µg/mL for 10 minutes at 37°C.
Immunostaining for BrdU and cell marker proteins (ie, von
Willebrand factor, α-smooth muscle actin [α-SMA], desmin,
and vimentin) was performed as described previously.17,18
The primary antibodies used in the present study were mouse
monoclonal anti-BrdU antibody (50:1 dilution), mouse
monoclonal F8/86 antibody recognizing von Willebrand fac-
tor (50:1 dilution), mouse monoclonal 1A4 antibody recog-
nizing α-SMA (50:1 dilution), mouse monoclonal D33 anti-
body recognizing desmin (100:1 dilution), and mouse
monoclonal V9 antibody recognizing vimentin (5:1 dilution;
all obtained from Dako JAPAN, Tokyo, Japan).
Immunohistochemical detection of apoptotic cells was
performed by a terminal deoxynucleotidyl transferase–
mediated dUTP nick end labeling (TUNEL) method19 using
a kit (Apop Tag Plus; Oncor Inc, Gaithersburg, Md). Double
immunofluorescence experiments to identify TUNEL-posi-
tive cells concomitant with desmin-expressing cells were
performed by the TUNEL method with fluorescein isothio-
cyanate–conjugated rabbit anti-sheep immunoglobulin G
(400:1 dilution; Dako) as a secondary antibody. The sec-
tions were then incubated with mouse monoclonal D33 anti-
body as described earlier, followed by staining with
tetrarhodamine isothiocyanate–conjugated rabbit anti-
mouse immunoglobulin G (200:1 dilution; Dako). The fluo-
rescence staining was viewed with confocal laser micro-
scope (Olympus Co, Tokyo, Japan).
Quantitative measurements. Neointimal areas were
delineated by the inner edge of the internal elastic laminae.
Medial areas were traced between the internal elastic laminae
and the inner border of the external elastic laminae.
Adventitial areas were defined between the inner border of
the external elastic laminae outward to the free edge of the
connective tissue. Intimal and medial thickness was mea-
sured in sections stained with elastica van Gieson stain with
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the use of a calibrated grid at 5 to 10 points of the middle por-
tion on 2 sections from each SV graft; the mean value was
calculated to obtain the data.
BrdU-labeled cells were counted on 3 sections from each
segment. TUNEL-positive cells with positive or negative
expression of desmin were identified by double immunofluo-
rescence confocal laser microscopy as described earlier. The
number of TUNEL-positive cells with positive immunofluo-
rescence staining for desmin in the media and those with neg-
ative immunofluorescence staining for desmin in the neointi-
ma were counted on 3 sections from each segment at
magnification ×600. The percentage of TUNEL-positive cells
was calculated by dividing the number of TUNEL-positive
cells with positive immunofluorescence staining for desmin
in the media or the number of those with negative immuno-
fluorescence staining for desmin in the neointima by the total
number of cells with a respective immunoreactivity pattern
for desmin in each layer.
Statistics. All numeric data are presented as mean ± SD.
One-way analysis of variance and the Scheffé multiple com-
parison test were used to compare the multigroup variables.
Results
Effects of BA1 on neointimal formation and medial
thickening. Elastica van Gieson stain showed no visible
intimal layer above the inner border of internal elastic
laminae in the freshly isolated SV segments after
preparation of culture (Fig l, A). After 14 days in cul-
ture, neointimal formation occurred above the inner
border of internal elastic laminae, associated with
marked thickening of the media (Fig l, B). Treatment of
cultured SV segments with 10 nmol/L of BA1 for 14
days abolished neointimal formation and medial thick-
ening (Fig 1, C).
Quantitative evaluation of the effect of BA1 on the
vessel wall hyperplasia showed that significant inhibi-
tion of neointimal formation and medial thickening
was evident by 5 nmol/L of BA1 (Fig 2). At 10 nmol/L,
BA1 completely inhibited neointimal formation and
medial thickening of the SV segments. A similar
inhibitory effect was observed with 10 nmol/L of con-
canamycin A, another macrolide antibiotic known as a
selective and potent inhibitor of V-ATPase.13 In con-
trast, FK-506 and erythromycin, which are the struc-
turally related macrolide antibiotics, failed to inhibit
neointimal formation and medial thickening at a con-
centration up to 1 µmol/L.
Effects of BA1 on endothelial cell coverage. The
freshly isolated SV segments were entirely covered with
a layer of endothelial cells in scanning electron
microscopy and immunostaining for von Willebrand
factor (Fig 3, A and D). All of the SV segments after 14
days in culture were led to complete uncoverage of
endothelial cells, which were replaced by neointimal
cells with smooth muscle cell–like morphologic fea-
tures (Fig 3, B and E). Cultivation of the SV segments
in the presence of 10 nmol/L of BA1 preserved endothe-
Fig 1. Transverse sections of human SV segments stained with elastica van Gieson. A, A freshly isolated vein seg-
ment before culture. B, A vein segment after 14 days in culture. C, A vein segment after 14 days in culture in the
presence of 10 nmol/L of bafilomycin Al. Arrowheads and arrows point to the internal elastic laminae and the exter-
nal elastic laminae, respectively. (Original magnification, ×40.)
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Fig 2. Effects of BA1 and the structurally related macrolide antibiotics on thickness of the neointima (A) and the
media (B). Human SV segments were cultured for 14 days in the absence or the presence of indicated concentra-
tions of BA1, concanamycin A, FK-506, and erythromycin. The filled bars indicate neointimal thickness; the open
bars indicate medial thickness. Preculture (n = 12), vehicle (n = 10), 5 nmol/L BA1 (n = 10), 10 nmol/L BA1 (n =
10), 10 nmol/L concanamycin A (n = 8), FK-506 (n = 10), erythromycin (n = 10). Results are expressed as mean
± SD. ND, Not detected. *P < .001; **P < .0001 vs vehicle.
A B
Fig 3. Intimal surface structure of human SV segments. Scanning electron micrographs (A-C; original magnifica-
tion, ×1000) and immunohistochemical staining for von Willebrand factor (D-F; original magnification, ×400) are
representative of 10 vein segments examined under each of the following conditions: A and D, a freshly isolated
vein segment before culture; B and E, a vein segment after 14 days in culture; and C and F, a vein segment after
14 days in culture in the presence of 10 nmol/L of BA1.
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lial cell coverage on the intimal surface (Fig 3, C and F).
Effects of BA1 on expression of cytoskeletal mark-
ers.  It has been proposed that neointimal cells prolifer-
ated after animal models of endoluminal injury of coro-
nary arteries and animal models of vein graft surgery
are myofibroblasts.17,18,20,21 This possibility was tested
in our organ culture model of human SV segments by
the determination of the expression of cytoskeletal pro-
tein markers (ie, α-SMA, desmin, and vimentin). The
freshly isolated SV segments showed bundles of
smooth muscle cell layers in the media, which were
positive for α-SMA and desmin (Fig 4, A and B). These
SV segments also contained non–muscle cells with
negative immunostaining for α-SMA and desmin but
positive immunostaining for vimentin, which were dis-
tributed between the medial smooth muscle cell layers
and in the adventitia (Fig 4, C). Immunohisto-
chemically detectable myofibroblasts, which have been
characterized by positive immunostaining for α-SMA
and vimentin but negative immunostaining for
desmin,22 were not found in the freshly isolated SV seg-
ments. The organ culture of the SV segments for 14
days markedly altered the distribution of the cells.
Although α-SMA–positive cells were distributed uni-
formly in the neointima (Fig 4, D), the neointimal cells
were exclusively negative for desmin but were positive
for vimentin (Fig 4, E and F). Thus the neointimal cells
expressed a phonotypic feature consistent with myofi-
broblasts. In the media, α-SMA–positive cells were dis-
tributed inhomogeneously, and most of the α-
SMA–positive cells were also positive for desmin or
vimentin. Because desmin is an intermediate filament
protein usually found only in muscle cells but not in
fibroblastic populations,23 this finding indicates that the
medial cells were composed of differentiated smooth
muscle cells and myofibroblasts. It should also be noted
that the number of smooth muscle cells with positive
immunostaining for desmin was reduced in comparison
to that in the freshly isolated SV segments. A consider-
able number of myofibroblasts were localized around
the free edge of the adventitia (not shown). The SV seg-
ments that were cultured in the presence of 10 nmol/L
of BA1 for 14 days showed bundles of cell layers with
immunoreactivity patterns for α-SMA and desmin,
similar to those observed in the freshly isolated SV seg-
ments and suggestive of differentiated smooth muscle
cells. In serial sections, α-SMA appeared to colocalize
with desmin in layers of the medial cells (Fig 4, G and
H). Only vimentin-positive non–muscle cells were dis-
tributed between the medial smooth muscle cell layers
and in the adventitia as observed in the freshly isolated
SV segments (Fig 4, I). Immunohistochemically
detectable myofibroblasts were not found in the BA1-
treated SV segments.
Effects of BA1 on BrdU uptake. BrdU was used to
identify proliferating cells in the cultured SV segments.
When BrdU was administered to the SV segments
between days 11 and 12 in culture, the intimal cells
incorporated BrdU in their nuclei (Fig 5, A).
Quantitative analysis of the number of BrdU-labeled
cells in the cultured SV segments without BA1 treat-
ment showed that 45.6% ± 20.1% (n = 8 segments) of
the neointimal cells expressed positive immunostaining
for BrdU. In contrast, incubation with BrdU in the
presence of 10 nmol/L of BA1 abrogated BrdU uptake
(0.8% ± 0.5%; n = 8) by the neointimal cells (Fig 5, B).
Effects of BA1 on apoptosis. These observations sug-
gest that BA1 induces the inhibition of neointimal for-
mation and that medial thickening may be caused by
growth arrest of myofibroblasts. However, it is also pos-
sible that BA1 could induce apoptotic cell death,15
which might be responsible for reducing the number of
myofibroblasts. This possibility was tested by the treat-
ment of SV segments with 50 nmol/L of BA1 between
days 11 and 12 in culture. Transmission electron
microscopy showed the characteristic morphologic fea-
tures of apoptosis in the neointimal cells within 24-hour
treatment with BA1. The neointimal cells showed chro-
matin condensation at the periphery of the nucleus asso-
ciated with cellular shrinkage and the formation of vesi-
cles in the presence of the intact plasma membrane (Fig
6, A). The neointimal cells underwent nuclear fragmen-
tation and disintegration of intracellular orgenelles after
the BA1 treatment for 48 hours (Fig 6, B). Most of the
neointimal cells were found to undergo apoptosis as
detected by TUNEL immunostaining after 48-hour
treatment with 50 nmol/L of BA1, although a smaller
number of TUNEL-positive cells were found in the
media (Fig 6, C). Under double immunofluorescence
confocal laser microscopy, TUNEL-positive cells in the
neointima were devoid of immunofluorescence staining
for desmin, whereas most of the medial cells expressing
desmin were negative for TUNEL (Fig 6, D).
The dose response effects of BA1 on the number of
TUNEL-positive cells with positive immunofluores-
cence staining for desmin and the number of those with
negative immunofluorescence staining for desmin were
tested by incubating 10-day cultured SV segments with
3 different concentrations of BA1 for 48 hours (Fig 7).
BA1 at a concentration of 5 nmol/L did not significant-
ly increase the number of TUNEL-positive cells, with
either immunoreactivity pattern for desmin. However,
10 nmol/L of BA1 significantly increased the number
of TUNEL-positive cells, with negative immunofluo-
rescence staining for desmin. BA1 at a concentration of
50 nmol/L induced apoptosis on more than two thirds
of cells with negative immunofluorescence staining for
desmin in the neointima, without a significant effect on
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Fig 4. Immunohistochemical staining for α-SMA, desmin, and vimentin. Serial sections obtained from the freshly isolated SV seg-
ment were immunostained for α-SMA (A), desmin (B), and vimentin (C). Note that vimentin-positive cells are distributed between
the medial smooth muscle cell layers (arrows) and in the adventitia (arrowhead). Serial sections obtained from the SV segment
after 14 days in culture were immunostained for α-SMA (D), desmin (E), and vimentin (F). Serial sections obtained from the SV
segment after 14 days in culture in the presence of 10 nmol/L of BA1 were immunostained for α-SMA (G), desmin (H), and
vimentin (I). The arrow points to the vimentin-positive cell. m, Media; a, adventitia; i, intima. (Original magnification, ×100.)
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the number of those cells with positive immunofluores-
cence staining for desmin in the media. These observa-
tions indicate that BA1 induces apoptosis on the neoin-
timal myofibroblasts and that those cells are more
susceptible to apoptosis by inhibition of V-ATPase
compared with the medial smooth muscle cells
expressing desmin.
Discussion
The present study is the first to propose that V-
ATPase may play a crucial role in vessel-wall hyper-
plasia. Neointimal formation and medial thickening
occurred in cultured human SV segments that had been
freshly isolated from the patients who had undergone
coronary artery bypass operations. Endothelial cells
were lost from the intimal surface and replaced by the
neointimal cells by 10 days in culture. Neointimal for-
mation, medial thickening, and the loss of endothelial
cells were prevented by nanomolar concentrations of
BA1 and concanamycin A but not by the structurally
related macrolide antibiotics FK-506 and ery-
thromycin. The highly selective nature of BA1 and con-
canamycin A to inhibit V-ATPase activity strongly sug-
gests that V-ATPase is involved in the vessel-wall
hyperplasia in cultured human SV segments.
The results of the present study argue for the poten-
tial role of myofibroblasts in vessel-wall hyperplasia
and suggest further that V-ATPase is crucial for myofi-
broblast growth. The freshly isolated SV segments did
not contain myofibroblasts, which have been character-
ized by positive immunostaining for α−SMA and
vimentin but negative immunostaining for desmin.22
However, myofibroblasts were grown in the neointima
during 14 days in culture. Cultivation of the SV seg-
ments in the presence of 10 nmol/L of BA1 inhibited
the emergence of myofibroblasts. The same concentra-
tion of BA1 abrogated BrdU uptake by the neointimal
cells in 10-day cultured SV segments. These results
indicate that BAl-induced suppression of neointimal
hyperplasia is not a consequence of the inhibition of
myofibroblast migration to the intima but is due to the
growth arrest of myofibroblasts and that BA1-induced
attenuation of medial thickening is also attributable to
reduced synthesis of extracellular matrix by myofi-
broblasts. We have previously demonstrated that both
BA1 and FK-506 are capable of inhibiting neointimal
hyperplasia in the cryopreserved rat aortic allograft.16
The evidence shown here substantiates the assumption
that BA1 and FK-506 inhibit neointimal hyperplasia
through a distinct mechanism (ie, V-ATPase inhibition
and immunosuppression, respectively).
The ability of BA1 to inhibit the emergence of myofi-
broblasts in cultured SV segments may not only result
from growth arrest but may also be ascribed to cell
death through apoptosis. The present study demonstrat-
ed that the treatment of 10-day cultured SV segments
with 50 nmol/L of BA1 for 48 hours produced morpho-
logic changes characteristic for apoptosis. Even lower
concentrations of BA1 significantly increased the num-
ber of TUNEL-positive cells. On the other hand,
endothelial cells and desmin-expressing smooth mus-
cle cells appear to have survived under the BA1 treat-
ment. The relative insensitivity of differentiated
smooth muscle cells to BA1 was documented by the
fact that desmin-positive smooth muscle cells in the
media withstood the 48-hour challenge of 50 nmol/L
BA1, which caused apoptosis on most desmin-negative
cells in the neointima.
Fig 5. Immunohistochemical staining for BrdU-labeled cells. The SV segment after 10 days in culture was incu-
bated with 50 µmol/L of BrdU for 48 hours in the absence or presence of 10 nmol/L of BA1. A, Incubation with
BrdU in the absence of BA1. B, Incubation with BrdU in the presence of BA1. i, Intima; m, media. (Original mag-
nification, ×400.)
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The molecular mechanisms underlying V-ATPase
involvement in myofibroblast growth remain elusive.
However, some pathophysiologic roles of V-ATPase in
regulating myofibroblast growth are anticipated from
the viewpoint that the stimulation of V-ATPase activity
could provide a desirable milieu for cell proliferation
and survival. First, acidification of vacuolar compart-
ments in eukaryotic cells by V-ATPase serves a number
of important functions for mitogenic activity, such as
insulin and epidermal growth factor receptor recycling
and reuse.24,25 Moreover, full mitogenic activity of
bFGF has been shown to require internalization of the
growth factor or the growth factor–receptor complex
by V-ATPase–dependent endocytosis followed by
translocation to the nucleus.26 Second, V-ATPase may
be involved in facilitating molecular transport across
organelle membranes. Unlike mitochondrial F-type H+-
ATPases which synthesize ATP at the expense of pro-
ton motive force, the vacuolar systems of eukaryotes
are energized primarily by V-ATPase that functions as
an ATP-dependent proton pump to generate proton
motive force.9 The electrochemical proton gradient is
used in driving the coupled transport of essential ions
and macromolecules, which are usually impermeant
Fig 6. The apoptotic neointimal cells detected with transmission electron microscopy (A and B) and with TUNEL
with the use of light microscopy (C) or confocal laser microscopy (D). The neointimal cell of the vein segment
treated with 50 nmol/L of BA1 for 24 hours after 10 days in culture shows chromatin condensation at the periph-
ery of the nucleus associated with cellular shrinkage and formation of vesicles in the presence of intact plasma
membrane (A). The neointimal cell shows nuclear fragmentation and disintegration of intracellular organelles after
48 hours of treatment with BA1 (B). (Original magnifications, A and B, ×8000.) C, The vein segment treated with
50 nmol/L of BA1 for 48 hours after 10 days in culture shows that most of the neointimal cells are positive for
TUNEL, although few medial cells are positive for these indices of apoptosis. i, Intima; m, media. (Original mag-
nification, ×200.) D, A serial section of the vein segment was doubly immunostained for TUNEL and desmin with
fluorescein isothiocyanate–conjugated and tetrarhodamine isothiocyanate–conjugated secondary antibodies,
respectively. The immunofluorescence staining was visualized with confocal laser microscopy. Note that the neoin-
timal cells with positive immunofluorescence for TUNEL (arrowhead) are negative for desmin, although medial
cells with negative immunofluorescence for TUNEL are positive for desmin (arrow). Bar, 10 µm.
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through vacuolar membranes. Therefore, the inhibition
of V-ATPase would result in the retardation of molec-
ular trafficking, leading to growth arrest and even cell
death. Finally, the activation of V-ATPase may be
involved in the regulation of cytosolic pH. The main-
tenance of cytosolic pH is crucial for cell growth and
survival. It has long been known that cytosolic alka-
linization provokes cell proliferation,27 whereas intra-
cellular acidosis is an important trigger for hypoxia-,
ischemia-, and irradiation-induced cell death.28-30 To
elucidate the exact role of V-ATPase in myofibroblast
growth, the function and localization of V-ATPase
remain to be investigated.
The present study was designed to address the pos-
sible involvement of V-ATPase in the vessel wall
hyperplasia with the use of an organ culture model of
human SV. This model allowed the resolution of spa-
tial and temporal distributions of vascular cells with-
in the vascular wall. However, this organ culture
model may be difficult to extrapolate directly to in
vivo situations, and the results should be interpreted
with caution. During 14 days of culture of the SV seg-
ments, it is likely that there are significant zones of
hypoxia, especially in the medial core, that may
increase susceptibility of the vascular cells to BA1,
leading to the overestimation of the proapoptotic
effect of BA1. However, our present study showed that
there was no increase in the number of TUNEL-posi-
tive cells in the media compared with the neointima,
irrespective of the absence or presence of BAl. In
addition, the preservation of endothelial cells by BA1
treatment is unlikely to be due to re-endothelialization
but is attributed to the inhibition of myofibroblast
growth. Nevertheless, preservation of endothelial
cells and differentiated smooth muscle cells in BA1-
treated SV segments provides significant clinical
implications, because these cells play an important
role in normal vascular physiologic and morphologic
features. Maintaining the integrity of vascular struc-
ture after vein graft surgery would prevent subsequent
progression of vein graft disease.
In conclusion, the present study provides a new
insight into the mechanism of neointimal formation.
The results suggest that V-ATPase may be involved in
myofibroblast growth that contributes to neointimal
formation and medial thickening in cultured human SV.
The inhibition of myofibroblast growth and preserva-
tion of endothelial cells and differentiated smooth mus-
cle cells by BA1 may have potential therapeutic impli-
cations in the treatment for vein graft disease.
We are grateful for technical assistance by Aya Kobayashi.
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